Hematology

Clinical pharmacy services in hematology can have a significant impact, and the Pharmacy Times® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.
[[thumbnail_alt_text]]
Brexucabtagene autoleucel (Tecartus, Kite Pharma) is indicated for adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment.
[[thumbnail_alt_text]]
The review also summarized proposed mechanisms behind these wide-ranging systemic effects and provided clinical guidance for physicians, according to a press release.
[[thumbnail_alt_text]]
The test is intended to determine whether someone is currently infected with COVID-19 and if they have been infected in the past.
[[thumbnail_alt_text]]
Caroline Bernal-Silva, a patient spokesperson for the National Blood Clot Alliance, discusses a recent survey regarding patients’ fears of a life-threatening bleeding event while taking anticoagulant medications.
[[thumbnail_alt_text]]
Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL).
[[thumbnail_alt_text]]
Experienced pharmacists in the management of chronic lymphocytic leukemia (CLL) discuss the impact of pharmacy-led oral chemotherapy management programs, and how they are implemented.
[[thumbnail_alt_text]]
A discussion on the economic impact that intravenous versus oral therapy has for institutions and patients.
 
[[thumbnail_alt_text]]
According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.
[[thumbnail_alt_text]]
The von Willebrand factor may be the reason why coronavirus disease 2019 presents itself so differently in each person.
 
[[thumbnail_alt_text]]
Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists.
[[thumbnail_alt_text]]
COVID-19 increases the risk of blood clotting due to increased activity in blood clotting cells.